ACRA in Ovarian Cancer Research

The Conquer Cancer - Susan & Teresa Schwab Ovarian Cancer Research Foundation Advanced Clinical Research Award (ACRA) in Ovarian Cancer Research is designed to fund mid-career physician scientists to conduct original and patient-oriented ovarian cancer research not currently funded and to establish a successful career path in this field. This grant mechanism is intended to support original and patient centric research proposals, including a clinical research study and/or translational research involving human subjects. Proposals must focus on high-grade serous ovarian carcinomas.

Funding Available and Award Term 

The ACRA is a three-year grant totaling $450,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting. There is funding for one ACRA in Ovarian Cancer Research. The project period is December 1, 2024 – November 30, 2027

Eligibility

Applicants must meet the following criteria for the ACRA in Ovarian Cancer Research:

• Be a physician (MD, DO, or international equivalent).
• Have completed productive post-doctoral/post fellowship research and demonstrated the ability to undertake independent investigator-initiated clinical research in ovarian cancer.
• At mid-career level, normally between fourth to ninth year from the first, full-time, primary faculty appointment in a clinical department at a US-based academic medical institution by the application deadline.
• Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, go to asco.org/membership.
• Be able to commit at least 75 percent of full-time effort in research (applies to total research, not just the proposed project) during the award period.
• Applicants who have previously received other grants from Conquer Cancer must be up-to-date and in compliance with all requirements (e.g. progress reports, final reports, budget summaries, IRB approvals, etc.) of any past grants.
• Eligible applicants are allowed to hold only one active grant from Conquer Cancer at a time.

Application Instructions

All applications must be submitted in accordance to the requirements and instructions of the Request for Proposals (RFP). All application materials must be in English and must be submitted through the Application Portal. Paper applications or applications sent by e-mail or fax will not be accepted.

Key Dates

Letter of Intent Due:                      June 10, 2024

Letter of Intent Notifications:          June 17, 2024

Full Application Due:                      August 12, 2024

Award Notification Date:               October 2024

Award Term:                                   December 1, 2024 – November 30, 2027